StockData
YD Bio Ltd logo

YD Bio Ltd (YDES) stock

YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 5/30
$4.73−0.10 (-2.07%)

Close on Nov 17, 2026Market cap $334.83MP/E –Yield –

YD Bio cash

Cash and short-term investments held at the end of each period.

YD Bio's cash was $2.66M at Jun 30, 2026. For fiscal 2025 it was $6.01M, up 91.8% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.01M+91.8%
FY2024Dec 31, 2024$3.13M+3496.3%
FY2023Dec 31, 2023$87.10K+189.0%
FY2022Dec 31, 2022$30.14K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.66M+2956.3%
Q4 FY2025Dec 31, 2025$6.01M+19831.0%
Q2 FY2025Jun 30, 2025$469.52K–
Q4 FY2024Dec 31, 2024$3.13M–
Q4 FY2023Dec 31, 2023$87.10K–
Q4 FY2022Dec 31, 2022$30.14K–

More YD Bio figures

See a number that looks wrong?